Kobe University AI Breakthrough: Accurate Acromegaly Diagnosis from Hand Images

Revolutionizing Rare Disease Detection: Kobe University's Privacy-First AI Approach

Kobe University researchers have achieved a groundbreaking advancement in medical diagnostics with an artificial intelligence (AI) model that accurately identifies acromegaly using only images of the back of the hand and a clenched fist. This innovation addresses longstanding challenges in diagnosing this rare endocrine disorder, which often evades detection for years due to its subtle, gradual onset. Published in the Journal of Clinical Endocrinology & Metabolism on February 27, 2026, the multicenter study demonstrates the model's superior performance over experienced endocrinologists, paving the way for efficient screening in everyday clinical settings.

Acromegaly, caused by excessive growth hormone (GH) production typically from a pituitary adenoma, leads to progressive enlargement of the hands, feet, facial features, and internal organs. Untreated, it shortens life expectancy by about 10 years through complications like cardiovascular disease, diabetes, and cancer. In Japan, prevalence mirrors global estimates at 3-4 cases per 100,000 people, yet diagnostic delays average 5-10 years due to nonspecific symptoms mimicking aging or other conditions.

Understanding Acromegaly: Symptoms, Causes, and Global Burden

Acromegaly (from Greek 'akron' meaning extremity and 'megaly' meaning enlargement) primarily affects adults aged 30-50, with a slight male predominance. Excess GH stimulates insulin-like growth factor 1 (IGF-1) production in the liver, driving abnormal tissue growth. Early signs include soft tissue swelling, joint pain, and coarsening facial features, progressing to enlarged extremities, deepened voice, excessive sweating, and sleep apnea. Internal effects encompass hypertension (up to 40% of cases), type 2 diabetes (25-50%), and colorectal polyps (higher cancer risk).

In Japan, epidemiological data from national registries indicate an incidence of about 3.3 per million annually, with over 5,000 estimated patients. Globally, delays stem from insidious progression; patients often consult multiple specialists before pituitary imaging and GH/IGF-1 testing confirm diagnosis. Treatment involves surgery, medications like somatostatin analogs, or radiation, but early intervention is crucial for reversing complications.

Diagnostic Challenges and the Need for Innovative Screening

Traditional diagnosis relies on clinical suspicion, elevated IGF-1 levels, failure of GH suppression in oral glucose tolerance tests, and MRI confirmation of pituitary tumors. However, nonspecific symptoms lead to oversight; studies report 48% of cases diagnosed incidentally during other evaluations. In rural Japan, access to endocrinologists exacerbates delays, contributing to healthcare disparities.

Prior AI efforts focused on facial recognition, achieving 93% accuracy but raising privacy issues under regulations like Japan's Act on the Protection of Personal Information. Hand images offer a non-invasive, routine alternative, as clinicians already inspect extremities for acromegaly signs like spade-like fingers or soft tissue thickening.

Prior AI Innovations in Acromegaly Detection

Earlier models, such as facial analysis tools from 2025, detected acromegaly pre-symptomatically with 86-93% accuracy but faced adoption barriers due to data privacy. A 2022 study using hand photos reported sensitivity of 98.3% and specificity 92%, yet lacked multicenter validation. Kobe University's work builds on these, prioritizing privacy by excluding palms and faces while incorporating real-world data variability.

The Kobe University Study: Methodology and Dataset

Led by Lecturer Hidenori Fukuoka and graduate student Yuka Ohmachi, the team collaborated with 15 institutions including Fukuoka University and Hokkaido University. They collected 11,000+ images from 725 participants (acromegaly patients and controls), capturing backs of hands and clenched fists under varied conditions to mimic clinical reality.

A deep learning convolutional neural network (CNN) was trained, fine-tuned for robustness. No facial or palm data ensured compliance with privacy standards, facilitating ethical data sharing.Read the full JCEM paper

• Dataset diversity: Multicenter, heterogeneous cameras/lighting.
• Privacy measures: Anonymized hand dorsum/fist only.
• Validation: Internal/external testing outperformed clinicians.

Impressive Results: AI Outperforms Human Experts

The model exhibited exceptional performance, with high sensitivity and specificity surpassing endocrinologists' photo-based assessments. Trained on real-world data, it handles variations effectively, promising reliable screening. Ohmachi noted surprise at accuracy sans facial cues, underscoring practicality.

Clinical Implications and Referral Systems

Integrable into routine checkups, the AI flags suspects for IGF-1 testing/specialist referral, accelerating diagnosis. Fukuoka envisions infrastructure reducing rural-urban gaps, aiding non-endocrinologists. In Japan, where comprehensive health exams are standard, this could screen millions efficiently.Explore AI research careers

Reducing Healthcare Disparities in Japan

Rural areas face specialist shortages; this tool empowers general practitioners. By complementing expertise, it minimizes oversights, enabling earlier surgery/medication to normalize GH levels and avert complications. Potential for telemedicine apps enhances equity.

Kobe University's Leadership in AI-Driven Medical Research

Kobe University Graduate School of Medicine exemplifies Japan's fusion of AI and endocrinology. Collaborations across 15 facilities highlight interdisciplinary strength. This positions Kobe as a hub for privacy-preserving diagnostics, attracting funding/talent. For aspiring researchers, opportunities abound in higher ed research positions blending machine learning and medicine.

Future Outlook: Expanding to Other Conditions

Next targets: rheumatoid arthritis (joint changes), anemia (pallor), finger clubbing (lung/heart issues). Scalable to smartphones, it could transform global screening. Challenges include regulatory approval, integration with EHRs, and bias mitigation.

Photo by Seoin Kim on Unsplash

• Rheumatoid arthritis detection via swelling.
• Anemia via skin tone variations.
• Finger clubbing for cardiopulmonary screening.

Career Opportunities in AI and Endocrinology

This breakthrough underscores demand for AI specialists in healthcare. Japanese universities like Kobe offer PhD/postdoc roles in computational medicine. Explore postdoc positions, research assistant jobs, or faculty openings via university jobs. For career advice, visit higher ed career advice.

In conclusion, Kobe University's hand-image AI heralds a new era in accessible diagnostics, exemplifying higher education's role in solving real-world health challenges. Stay informed on emerging research and opportunities in Japan's vibrant academic landscape.